SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-20-070289
Filing Date
2020-06-05
Accepted
2020-06-05 16:02:46
Documents
3
Group Members
DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm2021925d1_sc13g.htm SC 13G 47573
2 EXHIBIT 1 tm2021925d1_ex1.htm EX-99.1 5710
3 EXHIBIT 2 tm2021925d1_ex2.htm EX-99.2 5457
  Complete submission text file 0001104659-20-070289.txt   60584
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 20946113
SIC: 2834 Pharmaceutical Preparations